Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (6) | Back to Search
Efficacy and safety of aprepitant in japanese patients receiving high-dose chemotherapy followed by allogeneic hematopoietic stem cell transplantation
- In: Posters: Hospital Pharmacy Section
- At: Bangkok (Thailand) (2014)
- Type: Poster
- Poster code: POS-HPS036
- By: IKESUE, Hiroaki (Kyushu University Hospital, Department of Pharmacy, Fukuoka, Japan)
- Co-author(s): Uchida, Mayako (Kyushu University Hospital, Fukuoka, Japan)
Suetsugu, Kimitaka (Kyushu University Hospital, Fukuoka, Japan)
Nagata, Kenichiro (Kyushu University Hospital, Fukuoka, Japan)
Egashira, Nobuaki (Kyushu University Hospital, Fukuoka, Japan)
Masuda, Satohiro (Kyushu University Hospital, Fukuoka, Japan) - Abstract:
Background: Aprepitant, a neurokinin-1 receptor antagonist, has been shown to be effective for chemotherapy-induced nausea and vomiting. However, the usefulness of aprepitant in patients receiving high-dose chemotherapy followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT) still remains unclear.
Methods: We retrospectively.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023